Mr Richard Evans

Professional Services
- Senior Manager of the Clinical Trials Unit


Keppel Street
United Kingdom

020 7927 2665

My background is in trial management specialising in UK-based multicentre trials. I have worked in research for over 20 years, originally working on at Imperial College and for the past 13 years at London School of Hygiene and Tropical Medicine.

I work closely wth Professor Tim Clayton and the Cardiovascular Group in the LSHTM Clinical Trials Unit. In recent years we have delivered landmark trials such as REVIVED, ERIC-PPCI, ERICCA, AIMS, REPAIR and PREVENTT. Currently we are working on ARREST, BHF PROTECT-TAVI, CHIP-BCIS3 and Tight K. 

My interests are in all the operational aspects of clinical trials, from methodology, design feasibility, ethics and incorporating PPI. I have a particular interest in cardiovascular trials but have experience and interest in a number of other settings.


Department of Medical Statistics
Faculty of Epidemiology and Population Health


I manage a team of 10 trial managers, data managers and administrators in the LSHTM Clinical Trials Unit based in the Medical Statistics Department. I oversee a portfolio of trials, including ARREST, BHF PROTECT-TAVI, CHIP-BCIS3, REVIVED and Tight K.

My background is in trial management. I began work at the LSHTM CTU in 2011 coordinating the ERICCA trial, and in 2017 I became Senior Manager of the CTU. 

Research Area
Clinical trials
Disease and Health Conditions
Cardiovascular disease
United Kingdom
Europe & Central Asia (all income levels)
Euro area
European Union

Selected Publications

Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial.
Kharbanda RK; Perkins AD; Kennedy J; Banning AP; Baumbach A; Blackman DJ; Dodd M; Evans R; Hildick-Smith D; Jamal Z
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.
Perera D; Clayton T; O'Kane PD; Greenwood JP; Weerackody R; Ryan M; Morgan HP; Dodd M; Evans R; Canter R
New England Journal of Medicine
Effect of remote ischaemic conditioning on infarct size and remodelling in ST-segment elevation myocardial infarction patients: the CONDI-2/ERIC-PPCI CMR substudy.
Francis R; Chong J; Ramlall M; Bucciarelli-Ducci C; Clayton T; Dodd M; Engstrøm T; Evans R; Ferreira VM; Fontana M
Basic Research in Cardiology
Patient and public involvement prior to trial initiation: lessons learnt for rapid partnership in the COVID-19 era.
Jamal Z; Perkins A; Allen C; Research Advisory Group; Evans R; Sturgess J; Snowdon C; Clayton T; Elbourne D
Research involvement and engagement
Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial.
Richards T; Baikady RR; Clevenger B; Butcher A; Abeysiri S; Chau M; Macdougall IC; Murphy G; Swinson R; Collier T
Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.
Hausenloy DJ; Kharbanda RK; Møller UK; Ramlall M; Aarøe J; Butler R; Bulluck H; Clayton T; Dana A; Dodd M
Rationale and design of: A Randomized tRial of Expedited transfer to a cardiac arrest center for non-ST elevation out-of-hospital cardiac arrest: The ARREST randomized controlled trial.
Patterson T; Perkins A; Perkins GD; Clayton T; Evans R; Nguyen H; Wilson K; Whitbread M; Hughes J; Fothergill RT
American heart journal
See more Publications